Valuation: Arvee Laboratories (India) Ltd.

Market Cap 1.48B 15.43M 13.32M 12.52M 11.39M 21.41M 21.76M 147M 57.36M 739M 57.92M 56.66M 2.45B P/E 2024
151x
P/E 2025 72.9x
Enterprise Value 1.44B 15.02M 12.97M 12.19M 11.09M 20.85M 21.19M 143M 55.85M 719M 56.4M 55.17M 2.39B EV / Sales 2024
5.18x
EV / Sales 2025 3.96x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-0.28%
1 week+6.74%
Current month+5.63%
1 month+4.77%
3 months+6.53%
6 months-1.43%
Current year-22.40%
1 week 155.1
Extreme 155.1
189.39
1 month 147.15
Extreme 147.15
189.39
Current year 129.11
Extreme 129.11
208
1 year 129.11
Extreme 129.11
290.78
3 years 104
Extreme 104
315
5 years 62.9
Extreme 62.9
315
10 years 18.8
Extreme 18.8
315
Manager TitleAgeSince
Chief Executive Officer 52 2014-03-31
Director of Finance/CFO 43 2018-05-09
Compliance Officer 35 2019-02-14
Director TitleAgeSince
Chairman 52 2014-03-31
Director/Board Member 43 2025-08-11
Director/Board Member 43 2021-02-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+6.74%+0.70%+47.68% 19.13M
+0.20%+1.57%+37.61%+38.99% 74.47B
-1.05%-1.84%+9.34%+10.80% 50.99B
-1.42%-0.95%+8.49%+33.35% 18.02B
+0.29%+1.55%+50.13%+86.90% 14.4B
-1.20%-3.12%+49.29%+42.19% 10.32B
-1.42%-4.21%+12.73%-15.51% 10.26B
-0.36%+1.42%+5.48% - 9.73B
+0.05%+0.02%-10.93%+13.77% 8.09B
+2.34%+3.70%+87.31%-24.37% 7.29B
Average -0.28%+1.30%+25.01%+25.98% 20.36B
Weighted average by Cap. -0.36%+1.57%+26.49%+28.46%

Financials

2024 2025
Net sales 303M 3.17M 2.74M 2.58M 2.34M 4.4M 4.48M 30.18M 11.8M 152M 11.91M 11.66M 505M 385M 4.02M 3.48M 3.27M 2.97M 5.59M 5.68M 38.28M 14.97M 193M 15.11M 14.78M 640M
Net income 10.52M 110K 95.01K 89.28K 81.19K 153K 155K 1.05M 409K 5.27M 413K 404K 17.5M 21.47M 225K 194K 182K 166K 312K 317K 2.14M 835K 10.75M 843K 825K 35.73M
Net Debt -8.65M -90.51K -78.17K -73.46K -66.81K -126K -128K -861K -337K -4.33M -340K -332K -14.4M -38.73M -405K -350K -329K -299K -562K -571K -3.85M -1.51M -19.39M -1.52M -1.49M -64.45M
Logo Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Limited is an India-based company. The Company is engaged in manufacturing of specialized chemicals. It operates through Textile and Non-Textile segments. It offers polymer modifiers, contrast media intermediates, and drug intermediates. Its polumer modifier products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, and 5-Sodiosulfo-Bis-Isophthalate. Its contrast media intermediate products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, and 3,5-Diamino Benzoic Acid. Its drug intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine, and 2-Chloro-5-Nitrobenzoic Acid.
Employees
-
Date Price Change Volume
26-08-17 165.55 -0.28% 616
26-08-14 ₹166.01 -1.61% 1,929
26-08-13 ₹168.72 -4.81% 5,224
26-08-12 ₹177.24 +0.27% 17,422
26-08-11 ₹176.76 +13.97% 77,723
  1. Stock Market
  2. Stocks
  3. ARVEE Stock